Cohort Study for Patients Using Fuzeon (Enfuvirtide)

• Status: Unknown status
• Trial end date: 2006-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The Radata-Fuzeon cohort is an observational cohort study to gain a better understanding of Fuzeon (Enfuvirtide) in daily clinical practice. Patients planned to take this drug in a new antiretroviral combination therapy (ART) are eligible to participate in this observation.

Physicians may register patients online via the internet. They are offered to get an expert advice suggesting therapeutics for a new ART.

Observation interval is every three month. However physicians are allowed to initiate new diagnostics, expert advice and therapeutic changes independently from these intervals if necessary.

Total observation time for each patients is planned for two years.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Institute for Interdisciplinary Infectiology
• Collaborator: Hoffmann-La Roche
• Treatments: Anti-Retroviral Agents; Enfuvirtide

Criteria

Inclusion Criteria:

• Diagnosis of HIV-Infection

• Planned to switch to a Fuzeon-containing antiretroviral therapy

Exclusion Criteria:

• Inability to understand or sign inform consent